RxNorm Semantic Concepts Index - 246
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "246".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 246001 | Mephobarbital 90 MG / DPH 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246001 | Mephobarbital 90 MG / DPH 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246002 | APAP 325 MG / Methocarbamol 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246002 | APAP 325 MG / Methocarbamol 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246008 | alfacalcidol 0.25 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246008 | alfacalcidol 0.25 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246008 | alfacalcidol 0.25 MCG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 246008 | alfacalcidol 0.25 MCG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 246009 | alfacalcidol 0.0002 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246017 | ferrous ascorbate 275 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246018 | acenocoumarol 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246018 | acenocoumarol 1 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246018 | acenocoumarol 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246018 | acenocoumarol 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246018 | acenocoumarol 1 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246019 | acenocoumarol 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246019 | acenocoumarol 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246020 | Aprotinin 1.4 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246020 | Aprotinin 1.4 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 246020 | Aprotinin 1.4 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 246021 | ASA 330 MG / Dipyridamole 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246021 | ASA 330 MG / Dipyridamole 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246022 | framycetin 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246022 | framycetin 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246022 | framycetin 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246022 | framycetin 0.5 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 246022 | framycetin 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 246024 | methylprednisolone (as methylprednisolone sodium phosphate) 0.1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246024 | methylprednisolone (as methylprednisolone sodium phosphate) 0.1 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246024 | methylprednisolone (as methylprednisolone sodium phosphate) 0.1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246024 | methylprednisolone (as methylprednisolone sodium phosphate) 0.1 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246029 | phenylephrine 50 MG/ML / tropicamide 8 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24603 | Etizolam | Designated preferred name (PT) | NO | |
| RxCUI: 24603 | Etizolam | Full form of descriptor (FN) | NO | |
| RxCUI: 24603 | Etizolam | Designated preferred name (PT) | NO | |
| RxCUI: 24603 | Etizolam | Full form of descriptor (FN) | NO | |
| RxCUI: 246030 | clioquinol 1 % / flumethasone 0.02 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246030 | clioquinol 1 % / flumethasone 0.02 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246030 | clioquinol 1 % / flumethasone 0.02 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246030 | clioquinol 1 % / flumethasone 0.02 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246030 | clioquinol 1 % / flumethasone 0.02 % Otic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 246030 | clioquinol 1 % / flumethasone 0.02 % Otic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 246034 | hydrocortisone 0.005 MG/MG Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246045 | framycetin 0.015 MG/MG / gramicidin 0.00005 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24605 | Etodolac | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 24605 | Etodolac | Designated preferred name (PT) | YES | |
| RxCUI: 24605 | Etodolac | Full form of descriptor (FN) | YES | |
| RxCUI: 24605 | Etodolac | Designated preferred name (PT) | YES | |
| RxCUI: 24605 | Etodolac | Full form of descriptor (FN) | YES | |
| RxCUI: 2460530 | ethanol 0.658 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2460531 | isopropyl alcohol 0.049 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 246057 | bufexamac 0.05 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246060 | flumethasone 0.0002 MG/MG / salicylic acid 0.03 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246063 | colchicine 0.001 MG/MG / podophyllin 0.02 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2460630 | ethanol 65.8 % / isopropyl alcohol 4.9 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2460630 | ethanol 65.8 % / isopropyl alcohol 4.9 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2460630 | ethanol 65.8 % / isopropyl alcohol 4.9 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246064 | cetrimide 5 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246065 | cetrimide 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246065 | cetrimide 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246065 | cetrimide 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246066 | phenoxyethanol 17 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246067 | phenoxyethanol 25 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24607 | etofamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246070 | inositol niacinate 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246072 | cefamandole 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2460732 | methyl isobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 24608 | etofenamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 24608 | etofenamate | Designated preferred name (PT) | NO | |
| RxCUI: 24608 | etofenamate | Full form of descriptor (FN) | NO | |
| RxCUI: 24608 | etofenamate | Designated preferred name (PT) | NO | |
| RxCUI: 24608 | etofenamate | Full form of descriptor (FN) | NO | |
| RxCUI: 246080 | cyproterone 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246087 | pefloxacin 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246088 | pefloxacin 80 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246089 | lidocaine 3.33 MG/ML / rifamycin SV 83.3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24609 | etofibrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 24609 | etofibrate | Designated preferred name (PT) | NO | |
| RxCUI: 24609 | etofibrate | Full form of descriptor (FN) | NO | |
| RxCUI: 24609 | etofibrate | Designated preferred name (PT) | NO | |
| RxCUI: 24609 | etofibrate | Full form of descriptor (FN) | NO | |
| RxCUI: 246090 | dehydroemetine 30 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246091 | quinfamide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246092 | quinfamide 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246093 | albendazole 40 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246094 | fosfomycin 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246095 | fosfomycin 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246096 | fosfomycin 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246097 | fosfomycin 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246098 | nifuroxazide 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246099 | nifuroxazide 44 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246100 | tinidazole 67 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246101 | thiamphenicol 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246102 | thiamphenicol 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246105 | Sulfamoxole 400 MG / TMP 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246105 | Sulfamoxole 400 MG / TMP 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246106 | Sulfamoxole 40 MG/ML / TMP 8 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246106 | Sulfamoxole 40 MG/ML / TMP 8 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246107 | chlormadinone 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246108 | chlormadinone 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246109 | lynestrenol 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24611 | etofylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 24611 | etofylline | Designated preferred name (PT) | NO | |
| RxCUI: 24611 | etofylline | Full form of descriptor (FN) | NO | |
| RxCUI: 246110 | allylestrenol 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246110 | allylestrenol 5 MG Oral Tablet | British preferred term (PTGB) | NO | |
| RxCUI: 246110 | allylestrenol 5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246110 | allylestrenol 5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246111 | fendiline 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246112 | propafenone 70 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246113 | ketanserin 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461133 | ravulizumab-cwvz 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2461134 | ravulizumab-cwvz 1100 MG in 11 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2461134 | ravulizumab-cwvz 1100 MG in 11 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461134 | ravulizumab-cwvz 1100 MG in 11 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2461134 | ravulizumab-cwvz 1100 MG in 11 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461135 | ravulizumab-cwvz 100 MG/ML [Ultomiris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2461136 | ULTOMIRIS 1100 MG in 11 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2461136 | ULTOMIRIS 1100 MG in 11 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461136 | ULTOMIRIS 1100 MG in 11 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2461136 | ULTOMIRIS 1100 MG in 11 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461137 | ravulizumab-cwvz 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461138 | ravulizumab-cwvz 100 MG/ML Injection [Ultomiris] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2461138 | ravulizumab-cwvz 100 MG/ML Injection [Ultomiris] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2461139 | ravulizumab-cwvz 300 MG in 3 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2461139 | ravulizumab-cwvz 300 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461139 | ravulizumab-cwvz 300 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2461139 | ravulizumab-cwvz 300 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246114 | norfenefrine 15 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461140 | ULTOMIRIS 300 MG in 3 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2461140 | ULTOMIRIS 300 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461140 | ULTOMIRIS 300 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2461140 | ULTOMIRIS 300 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461142 | Coccinia grandis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2461143 | N-alkyl dimethyl benzyl ammonium ion (C12-C18) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2461144 | N-dialkyl methyl benzyl ammonium chloride (C12-C18) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2461147 | Bismuth chelate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246115 | norfenefrine 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246116 | benzarone 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246117 | buflomedil 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246118 | buflomedil 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246119 | buflomedil 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246120 | naftidrofuryl oxalate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246120 | naftidrofuryl oxalate 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246120 | naftidrofuryl oxalate 100 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 246120 | naftidrofuryl oxalate 100 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 246121 | nafronyl 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246122 | isothipendyl 12 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246123 | isothipendyl 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246125 | chloropyramine 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246126 | chloropyramine 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246127 | ketotifen fumarate 1 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246127 | ketotifen fumarate 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246127 | ketotifen fumarate 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246127 | ketotifen fumarate 1 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246129 | ketotifen 0.2 MG/ML Oral Solution | Designated preferred name (PT) | NO | |
| RxCUI: 246129 | ketotifen 0.2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246129 | ketotifen 0.2 MG/ML Oral Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 246130 | oxatomide 2.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246131 | dipropizine 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246133 | dipropizine 20 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461333 | dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2461338 | atoltivimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2461338 | atoltivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2461338 | atoltivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2461339 | maftivimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2461339 | maftivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2461339 | maftivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 246134 | zipeprol 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461340 | odesivimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2461340 | odesivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2461340 | odesivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 246137 | zipeprol 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246138 | bromhexine 4 MG per 5 ML Elixir | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246138 | bromhexine 4 MG per 5 ML Elixir | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246138 | bromhexine 4 MG per 5 ML Elixir | Designated preferred name (PT) | NO | |
| RxCUI: 246138 | bromhexine 4 MG per 5 ML Elixir | Full form of descriptor (FN) | NO | |
| RxCUI: 246139 | bromhexine 1.6 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24614 | etoposide phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 24614 | etoposide phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 24614 | etoposide phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 246140 | ambroxol 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246141 | ambroxol 3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246142 | ambroxol 7.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246143 | clenbuterol 0.02 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461430 | atoltivimab-ebgn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2461431 | atoltivimab-ebgn 16.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2461432 | maftivimab-ebgn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2461433 | maftivimab-ebgn 16.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2461434 | odesivimab-ebgn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2461435 | odesivimab-ebgn 16.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2461436 | atoltivimab / maftivimab / odesivimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2461436 | atoltivimab / maftivimab / odesivimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2461436 | atoltivimab / maftivimab / odesivimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2461437 | atoltivimab / maftivimab / odesivimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 246144 | clenbuterol 0.001 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246145 | tulobuterol 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246146 | tulobuterol 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246147 | tulobuterol 0.2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246149 | proxyphylline 150 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246150 | picosulfate sodium 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246153 | prifinium 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461531 | Inmazeb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2461532 | atoltivimab / maftivimab / odesivimab Injection [Inmazeb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2461533 | atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML Injection [Inmazeb] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2461534 | Inmazeb Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2461535 | atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461536 | atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2461536 | atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461536 | atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461536 | atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2461536 | atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461537 | atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML [Inmazeb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2461538 | atoltivimab / maftivimab / odesivimab | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2461538 | atoltivimab / maftivimab / odesivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2461538 | atoltivimab / maftivimab / odesivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2461539 | Inmazeb 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2461539 | Inmazeb 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461539 | Inmazeb 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2461539 | Inmazeb 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2461539 | Inmazeb 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246154 | prifinium 7.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461541 | ethanol 0.792 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2461542 | ethanol 79.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461542 | ethanol 79.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2461542 | ethanol 79.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246155 | propinox 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246156 | propinox 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246157 | propinox 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246158 | pinaverium bromide 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246158 | pinaverium bromide 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246158 | pinaverium bromide 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246159 | trimebutine 20 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246160 | trimebutine 5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246161 | trimebutine 23 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246162 | cinnarizine 150 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246163 | cinnarizine 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246164 | hymecromone 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246165 | silybin 70 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246166 | nifuratel 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246167 | nifuratel 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246168 | nifuratel 4 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246171 | bromazepam 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246172 | cloBAZam 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 246172 | cloBAZam 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 246172 | cloBAZam 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 246173 | tetrazepam 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246174 | butriptyline 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246175 | butriptyline 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246176 | butriptyline 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246179 | mianserin 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246180 | sulpiride 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246181 | flunitrazepam 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246182 | clobenzorex 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246183 | nicergoline 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246184 | nicergoline 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246185 | pyrithioxin 16.1 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246186 | pyrithioxin 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246187 | vincamine 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246188 | vincamine 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246190 | nefopam 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246191 | nefopam 2 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246191 | nefopam 2 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246191 | nefopam 2 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246191 | nefopam 2 % Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 246191 | nefopam 2 % Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 246192 | glucametacin 140 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246193 | bumadizone 110 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246194 | bumadizone 220 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246195 | APAP 300 MG / Tolperisone 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246195 | APAP 300 MG / Tolperisone 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246196 | vit-B1 Pyrophosphate 40 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246196 | vit-B1 Pyrophosphate 40 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246196 | vit-B1 Pyrophosphate 40 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246197 | sodium acexamate 0.05 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2461970 | Sigesbeckia orientalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2461971 | glycerophosphoinositol lysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2461972 | benzalkonium chloride 1.5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2461972 | benzalkonium chloride 1.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2461972 | benzalkonium chloride 1.5 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246199 | Hexetidine 1 mg/mL oromucosal solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246199 | Hexetidine 1 mg/mL oromucosal solution | Designated preferred name (PT) | NO | |
| RxCUI: 246199 | Hexetidine 1 mg/mL oromucosal solution | Full form of descriptor (FN) | NO | |
| RxCUI: 246200 | rifamycin SV 10 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462009 | synthetic beeswax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2462010 | benzocaine 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2462011 | benzocaine 12 % / lidocaine HCl 4 % / tetracaine HCl 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462011 | benzocaine 12 % / lidocaine HCl 4 % / tetracaine HCl 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462011 | benzocaine 12 % / lidocaine HCl 4 % / tetracaine HCl 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462012 | benzocaine / lidocaine / tetracaine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2462013 | benzocaine 12 % / lidocaine HCl 4 % / tetracaine HCl 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462013 | benzocaine 12 % / lidocaine HCl 4 % / tetracaine HCl 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462013 | benzocaine 12 % / lidocaine HCl 4 % / tetracaine HCl 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462014 | methyl salicylate 480 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2462015 | camphor 10 % / menthol 15 % / methyl salicylate 48 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462015 | camphor 10 % / menthol 15 % / methyl salicylate 48 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462015 | camphor 10 % / menthol 15 % / methyl salicylate 48 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462016 | epinephrine hydrochloride 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2462016 | epinephrine hydrochloride 0.1 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2462017 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462017 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462017 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Topical Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2462017 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462017 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Topical Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246202 | polynoxylin 0.1 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462023 | tiotropium bromide, anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 2462023 | tiotropium bromide, anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 2462023 | tiotropium bromide, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 246203 | tolciclate 10 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246204 | isothipendyl 0.0075 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246206 | etofenamate 0.05 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246206 | etofenamate 0.05 MG/MG Topical Gel | Designated preferred name (PT) | NO | |
| RxCUI: 246206 | etofenamate 0.05 MG/MG Topical Gel | Full form of descriptor (FN) | NO | |
| RxCUI: 246207 | monosulfiram 250 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246208 | serratiopeptidase 5 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246212 | aluminum phosphate 153 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246214 | cimetidine 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462144 | trisodium HEDTA monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2462145 | Impeklo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2462146 | clobetasol propionate 0.5 MG/ML [Impeklo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2462147 | clobetasol Topical Lotion [Impeklo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2462148 | Impeklo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2462149 | Impeklo 0.05 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2462149 | Impeklo 0.05 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2462149 | Impeklo 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462149 | Impeklo 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462149 | Impeklo 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246215 | cimetidine 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462150 | stannous chloride dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2462151 | menthone 1,2-glycerol ketal, (+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462152 | silver carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246217 | cisapride (as cisapride monohydrate) 1 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246217 | cisapride (as cisapride monohydrate) 1 MG/ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 246217 | cisapride (as cisapride monohydrate) 1 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246217 | cisapride (as cisapride monohydrate) 1 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246217 | cisapride (as cisapride monohydrate) 1 MG/ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 246218 | metoclopramide 20 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246219 | metoclopramide 4 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246220 | metoclopramide 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462207 | chlorocitric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246221 | mesalamine 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246227 | tetrazepam 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246228 | perphenazine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246229 | Product containing precisely thioridazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 246229 | Product containing precisely thioridazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 246229 | Product containing precisely thioridazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246230 | ergoloid mesylates 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246230 | ergoloid mesylates 1.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246231 | ergoloid mesylates, USP 4.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246232 | ergoloid mesylates, USP 0.3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246233 | diazepam 2.5 MG / sulpiride 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246233 | diazepam 2.5 MG / sulpiride 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246235 | ketoprofen 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246236 | Ketoprofen 50 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246236 | Ketoprofen 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 246236 | Ketoprofen 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 246237 | ketoprofen 7.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246238 | naproxen 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246239 | naproxen 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246240 | naproxen 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246241 | naproxen 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246242 | naproxen 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246243 | piroxicam 20 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246244 | piroxicam 40 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462445 | PEG-50 shea butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 246245 | piroxicam 7.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462454 | Gastrodia elata tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462455 | ethanol 73 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462455 | ethanol 73 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462455 | ethanol 73 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462458 | 5-hydroxytryptophan, D- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462459 | Nevirapine hemihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2462459 | Nevirapine hemihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 2462459 | Nevirapine hemihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 246246 | Piroxicam 20 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246246 | Piroxicam 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 246246 | Piroxicam 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 246249 | tolmetin 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462493 | Cardamom oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462493 | Cardamom oil | Designated preferred name (PT) | NO | |
| RxCUI: 2462493 | Cardamom oil | Full form of descriptor (FN) | NO | |
| RxCUI: 2462494 | nonapeptide-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462495 | Salvadora persica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2462496 | Aminopromazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2462496 | Aminopromazine | Designated preferred name (PT) | YES | |
| RxCUI: 2462496 | Aminopromazine | Full form of descriptor (FN) | YES | |
| RxCUI: 2462497 | Lactobacillus gasseri | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462498 | heptyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462499 | lactic acid, L- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 246250 | ornidazole 167 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462500 | silver sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462501 | Perfluorodecalin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2462501 | Perfluorodecalin | Designated preferred name (PT) | YES | |
| RxCUI: 2462501 | Perfluorodecalin | Full form of descriptor (FN) | YES | |
| RxCUI: 2462501 | Perfluorodecalin | Designated preferred name (PT) | YES | |
| RxCUI: 2462501 | Perfluorodecalin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462501 | Perfluorodecalin | Full form of descriptor (FN) | YES | |
| RxCUI: 2462502 | methoxyisopropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2462503 | Oryctolagus cuniculus pancreatin preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2462504 | camphor 3 % / menthol 7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462504 | camphor 3 % / menthol 7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462504 | camphor 3 % / menthol 7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462506 | Aquaphor Itch Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2462507 | hydrocortisone 0.01 MG/MG [Aquaphor Itch Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2462508 | hydrocortisone Topical Ointment [Aquaphor Itch Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2462509 | Aquaphor Itch Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 246251 | chloramphenicol 45.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462510 | Aquaphor Itch Relief 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462510 | Aquaphor Itch Relief 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2462510 | Aquaphor Itch Relief 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462510 | Aquaphor Itch Relief 1 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2462511 | etanercept-ykro | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2462512 | etanercept-ykro 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2462513 | etanercept-ykro 50 MG in 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462513 | etanercept-ykro 50 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462513 | etanercept-ykro 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462514 | Eticovo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2462515 | etanercept-ykro 50 MG/ML [Eticovo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2462516 | etanercept Prefilled Syringe [Eticovo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2462517 | Eticovo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2462518 | Eticovo 50 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2462518 | Eticovo 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462518 | Eticovo 50 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462518 | Eticovo 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462519 | etanercept-ykro 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246252 | SMX 80 MG/ML / TMP 16 MG/ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 246252 | SMX 80 MG/ML / TMP 16 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246252 | SMX 80 MG/ML / TMP 16 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246252 | SMX 80 MG/ML / TMP 16 MG/ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2462520 | etanercept-ykro 50 MG/ML Prefilled Syringe [Eticovo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2462520 | etanercept-ykro 50 MG/ML Prefilled Syringe [Eticovo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462521 | etanercept-ykro 25 MG in 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2462521 | etanercept-ykro 25 MG in 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2462521 | etanercept-ykro 25 MG in 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462522 | Eticovo 25 MG in 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2462522 | Eticovo 25 MG in 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2462522 | Eticovo 25 MG in 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2462522 | Eticovo 25 MG in 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246253 | SMX 267 MG/ML / TMP 53.3 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246253 | SMX 267 MG/ML / TMP 53.3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246255 | betamethasone 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246256 | fluoxymesterone 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246257 | mestranol 0.1 MG / norethindrone 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246258 | medroxyPROGESTERone 50 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246258 | medroxyPROGESTERone 50 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246259 | deslanoside 0.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246261 | 12 HR diltiazem 180 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246261 | 12 HR diltiazem 180 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246262 | NIFEdipine 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246262 | NIFEdipine 20 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246262 | NIFEdipine 20 MG Extended Release Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246262 | NIFEdipine 20 MG Extended Release Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246263 | quiNIDine 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246263 | quiNIDine 250 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246264 | enalaprilat 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246266 | ketanserin 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462661 | Styphnolobium japonicum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246267 | HCTZ 12.5 MG / Metoprolol 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246267 | HCTZ 12.5 MG / Metoprolol 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246267 | HCTZ 12.5 MG / Metoprolol 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246270 | astemizole 1 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246271 | terfenadine 30 MG per 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246271 | terfenadine 30 MG per 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246274 | benzonatate 50 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246275 | benzonatate 100 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246279 | clenbuterol 0.01 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462794 | C8-10 alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246280 | theophylline 500 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462800 | benzalkonium chloride 16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2462801 | benzalkonium chloride 1.6 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462801 | benzalkonium chloride 1.6 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462801 | benzalkonium chloride 1.6 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462802 | benzalkonium chloride 1.6 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462802 | benzalkonium chloride 1.6 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462802 | benzalkonium chloride 1.6 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246281 | amoxicillin 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246282 | amoxicillin (as amoxicillin trihydrate) 100 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246282 | amoxicillin (as amoxicillin trihydrate) 100 MG/ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 246282 | amoxicillin (as amoxicillin trihydrate) 100 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246282 | amoxicillin (as amoxicillin trihydrate) 100 MG/ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 246283 | ampicillin 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246284 | ampicillin 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246285 | ampicillin 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246286 | dicloxacillin 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246290 | cephradine 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246293 | oxytetracycline 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2462930 | benzalkonium chloride 1.56 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2462931 | benzalkonium chloride 0.156 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2462931 | benzalkonium chloride 0.156 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2462931 | benzalkonium chloride 0.156 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246295 | ciprofloxacin 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246297 | Rifampicin 20 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 246297 | Rifampicin 20 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246297 | Rifampicin 20 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 246297 | Rifampicin 20 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246297 | Rifampicin 20 mg/mL oral suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246298 | iodoquinol 42 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246299 | quinfamide 10 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246300 | mebendazole 20 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246300 | mebendazole 20 MG/mL Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 246300 | mebendazole 20 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246300 | mebendazole 20 MG/mL Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 246301 | praziquantel 150 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246301 | praziquantel 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246301 | praziquantel 150 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246302 | furazolidone 30 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246303 | metroNIDAZOLE 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246303 | metroNIDAZOLE 50 MG/ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246306 | clonazePAM 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246306 | clonazePAM 2.5 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246307 | DPH 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246307 | DPH 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246311 | biperiden 4 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463110 | Cocaine esterase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463110 | Cocaine esterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463112 | gelatin type B bovine (150 bloom) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2463114 | bamlanivimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2463114 | bamlanivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2463114 | bamlanivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2463114 | bamlanivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2463114 | bamlanivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2463115 | bamlanivimab 35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2463116 | bamlanivimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2463116 | bamlanivimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2463116 | bamlanivimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2463117 | bamlanivimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2463118 | bamlanivimab 700 MG in 20 mL Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2463118 | bamlanivimab 700 MG in 20 mL Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2463118 | bamlanivimab 700 MG in 20 mL Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463119 | bamlanivimab 35 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246313 | vitamin K1 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246313 | vitamin K1 10 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246313 | vitamin K1 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246313 | vitamin K1 10 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246313 | vitamin K1 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246313 | vitamin K1 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246316 | ferrous aspartate 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246317 | ferrous aspartate 35 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246318 | FESO4 152 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246318 | FESO4 152 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246319 | pentoxifylline 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246320 | kanamycin 3.5 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246321 | kanamycin 0.0035 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246323 | naproxen 0.1 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246324 | podophyllin 0.25 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246325 | lidocaine 0.03 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246326 | methoxsalen 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246327 | 5-FU 0.05 MG/MG Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246327 | 5-FU 0.05 MG/MG Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246327 | 5-FU 0.05 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246328 | penicillamine 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246328 | penicillamine 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246329 | penicillin G 600000 UNT Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246330 | penicillin V 650 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463332 | acetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2463332 | acetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463332 | acetaminophen 500 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463333 | decyl gallate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463334 | Hibiscus bifurcatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2463335 | Pseudotsuga menziesii resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463336 | aminopropyl dimethicone (1000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463337 | AQP-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463337 | AQP-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463337 | AQP-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463337 | AQP-1 | Designated preferred name (PT) | NO | |
| RxCUI: 2463337 | AQP-1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2463340 | calcium fluorophosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463340 | calcium fluorophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246335 | amoxicillin 500 MG / bromhexine 8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246336 | amoxicillin 50 MG/ML / bromhexine 0.8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246337 | amoxicillin 50 MG/ML / bromhexine 1.6 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246338 | ampicillin 250 MG / dicloxacillin 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246342 | ampicillin 250 MG / bromhexine 8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246343 | ampicillin 500 MG / bromhexine 8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246344 | ampicillin 25 MG/ML / bromhexine 0.8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246345 | ampicillin 50 MG/ML / bromhexine 0.8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246350 | bromhexine 8 MG / erythromycin 500 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246351 | chlortetracycline 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246352 | chlortetracycline 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246353 | ciprofloxacin 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463530 | PEG-32 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 246356 | INH 200 MG / Rifampin 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246356 | INH 200 MG / Rifampin 150 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246356 | INH 200 MG / Rifampin 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246356 | INH 200 MG / Rifampin 150 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246357 | INH 75 MG / PZA 400 MG / Rifampin 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246357 | INH 75 MG / PZA 400 MG / Rifampin 150 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246357 | INH 75 MG / PZA 400 MG / Rifampin 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246357 | INH 75 MG / PZA 400 MG / Rifampin 150 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246358 | metaproterenol 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246361 | phthalylsulfathiazole 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246370 | secnidazole 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246371 | secnidazole 25 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463730 | Syzygium jambos fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2463731 | epoetin alfa-epbx 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463731 | epoetin alfa-epbx 10,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2463731 | epoetin alfa-epbx 10,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2463731 | epoetin alfa-epbx 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463731 | epoetin alfa-epbx 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463732 | epoetin alfa Injectable Solution [Retacrit] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2463733 | Retacrit 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463733 | Retacrit 10,000 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2463733 | Retacrit 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463733 | Retacrit 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463733 | Retacrit 10,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2463733 | Retacrit 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463734 | epoetin alfa-epbx 20000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2463735 | epoetin alfa-epbx 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463735 | epoetin alfa-epbx 20,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2463735 | epoetin alfa-epbx 20,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2463735 | epoetin alfa-epbx 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463736 | epoetin alfa-epbx 20000 UNT/ML [Retacrit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2463737 | Retacrit 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463737 | Retacrit 20,000 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2463737 | Retacrit 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463737 | Retacrit 20,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2463737 | Retacrit 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2463738 | Gracilaria gracilis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2463741 | Gemmily 1 MG / 20 MCG 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2463741 | Gemmily 1 MG / 20 MCG 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2463741 | Gemmily 1 MG / 20 MCG 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246375 | iodoquinol 200 MG / metronidazole 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246375 | iodoquinol 200 MG / metronidazole 400 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246376 | metronidazole 500 MG / scopolamine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246376 | metronidazole 500 MG / scopolamine 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246377 | metronidazole 25 MG/ML / scopolamine 1 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246377 | metronidazole 25 MG/ML / scopolamine 1 MG/ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246378 | Rifampin 300 MG / TMP 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246378 | Rifampin 300 MG / TMP 80 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246378 | Rifampin 300 MG / TMP 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246378 | Rifampin 300 MG / TMP 80 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246383 | cloprednol 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463830 | benzalkonium chloride 0.016 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2463831 | benzalkonium chloride 1.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463831 | benzalkonium chloride 1.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2463831 | benzalkonium chloride 1.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246384 | cloprednol 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246387 | estradiol 5 MG/ML / progesterone 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246389 | algestone 75 MG/ML / estradiol 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246390 | algestone 150 MG/ML / estradiol 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246391 | glyburide 2.5 MG / phenformin 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246391 | glyburide 2.5 MG / phenformin 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246392 | tolrestat 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463930 | benzalkonium chloride 1.6 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2463930 | benzalkonium chloride 1.6 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463930 | benzalkonium chloride 1.6 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463932 | sodium bisulfate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2463933 | indican | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463934 | camphor 4 % / menthol 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2463934 | camphor 4 % / menthol 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463934 | camphor 4 % / menthol 3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463935 | 4-desoxypyridoxine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2463936 | 4-desoxypyridoxine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2463937 | menthol 9 % / methyl salicylate 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2463937 | menthol 9 % / methyl salicylate 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463937 | menthol 9 % / methyl salicylate 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2463938 | turpentine 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2463939 | turpentine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2463940 | turpentine Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2463941 | turpentine 50 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2463941 | turpentine 50 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2463941 | turpentine 50 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246395 | 12 HR diltiazem 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246395 | 12 HR diltiazem 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246396 | gallopamil 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246397 | niMODipine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246397 | niMODipine 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246399 | spironolactone 50 MG / furosemide 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246399 | spironolactone 50 MG / furosemide 20 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 246399 | spironolactone 50 MG / furosemide 20 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 246399 | spironolactone 50 MG / furosemide 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246401 | buflomedil 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246407 | pipazethate 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464104 | ethanol 0.713 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2464105 | isopropyl alcohol 0.0375 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2464106 | ethanol 71.25 % / isopropyl alcohol 3.75 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464106 | ethanol 71.25 % / isopropyl alcohol 3.75 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2464106 | ethanol 71.25 % / isopropyl alcohol 3.75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464107 | benzalkonium chloride 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2464108 | benzalkonium chloride 0.8 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2464108 | benzalkonium chloride 0.8 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464108 | benzalkonium chloride 0.8 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246420 | ambroxol 1.5 MG/ML / clenbuterol 0.001 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246421 | bromhexine 1.6 MG/ML / fenoterol 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246422 | guaifenesin 13.3 MG/ML / terbutaline 0.3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246422 | guaifenesin 13.3 MG/ML / terbutaline 0.3 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246424 | oxytetracycline 125 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246427 | etofamide 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246428 | etofamide 20 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464290 | 10-(N-methylpiperidyliden-4)-1-azathioxanthene malonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2464291 | diethyl azelate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2464304 | iron-dextran complex 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2464305 | iron-dextran complex (iron 200 MG/ML) Injectable solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464305 | iron-dextran complex (iron 200 MG/ML) Injectable solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464305 | iron-dextran complex (iron 200 MG/ML) Injectable solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464306 | iron-dextran complex 200 MG/ML [Uniferon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2464307 | iron-dextran complex 200 MG/ML Injectable Solution [Uniferon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2464307 | iron-dextran complex 200 MG/ML Injectable Solution [Uniferon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464307 | iron-dextran complex 200 MG/ML Injectable Solution [Uniferon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464312 | Lilium candidum flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246432 | iodoquinol 20 MG/ML / metronidazole 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246432 | iodoquinol 20 MG/ML / metronidazole 25 MG/ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246433 | Sulfalene 200 MG / TMP 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246433 | Sulfalene 200 MG / TMP 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464333 | lidocaine Topical Spray [Alocane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2464334 | Alocane 4 % Topical Spray Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464334 | Alocane 4 % Topical Spray Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2464334 | Alocane 4 % Topical Spray Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464334 | Alocane 4 % Topical Spray Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464334 | Alocane 4 % Topical Spray Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2464338 | secobarbital sodium 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 246434 | Sulfalene 8 MG/ML / TMP 10 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246434 | Sulfalene 8 MG/ML / TMP 10 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464341 | secobarbital sodium 100 MG [Seconal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2464343 | Seconal Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2464344 | Seconal Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2464346 | magnesium sulfate Granules for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 246435 | sulfametrole 400 MG / TMP 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246435 | sulfametrole 400 MG / TMP 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246436 | sulfametrole 40 MG/ML / TMP 8 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246436 | sulfametrole 40 MG/ML / TMP 8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246444 | flunarizine 5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246444 | flunarizine 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246444 | flunarizine 5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246445 | flunarizine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246453 | dyphylline 200 MG / guaifenesin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246453 | dyphylline 200 MG / guaifenesin 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2464539 | embutramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246454 | aloglutamol 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464540 | pyrithione sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 246455 | aloglutamol 200 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246456 | belladonna extract, USP 0.07 MG / PHENobarbital 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246456 | belladonna extract, USP 0.07 MG / PHENobarbital 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246457 | pipemidic acid 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246458 | pemoline 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246459 | vincamine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246460 | aspirin 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246460 | aspirin 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246460 | aspirin 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246461 | aspirin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246461 | aspirin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246461 | aspirin 100 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246461 | aspirin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246461 | aspirin 100 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246465 | lidocaine 10 MG/ML / phenylbutazone 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246466 | APAP 300 MG / Naproxen 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246466 | APAP 300 MG / Naproxen 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246467 | APAP 20 MG/ML / Naproxen 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246467 | APAP 20 MG/ML / Naproxen 25 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246468 | APAP 200 MG / Naproxen 100 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246468 | APAP 200 MG / Naproxen 100 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246473 | nitrendipine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246474 | buprenorphine 0.2 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246474 | buprenorphine 0.2 MG Sublingual Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246474 | buprenorphine 0.2 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246474 | buprenorphine 0.2 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246474 | buprenorphine 0.2 MG Sublingual Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246475 | indomethacin 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246476 | allopurinol 75 MG / probenecid 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246477 | DPH 7.5 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246477 | DPH 7.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246478 | Phenobarbital 50 MG / DPH 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246478 | Phenobarbital 50 MG / DPH 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246478 | Phenobarbital 50 MG / DPH 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246478 | Phenobarbital 50 MG / DPH 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246480 | carisoprodol 200 MG / naproxen 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246481 | carisoprodol 200 MG / naproxen 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246482 | APAP 350 MG / Methocarbamol 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246482 | APAP 350 MG / Methocarbamol 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464823 | modified Vaccinia Ankara-Bavarian Nordic | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2464824 | modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2464825 | vaccinia virus Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2464826 | vaccinia virus Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2464827 | modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT in 1 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2464827 | modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT in 1 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464827 | modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT in 1 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2464827 | modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT in 1 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464827 | modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT in 1 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464828 | Jynneos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2464829 | modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML [Jynneos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 246483 | indomethacin 25 MG / methocarbamol 215 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464830 | vaccinia virus Injection [Jynneos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2464831 | Jynneos Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2464832 | JYNNEOS smallpox and monkeypox vaccine, live 0.5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2464832 | JYNNEOS smallpox and monkeypox vaccine, live 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2464832 | JYNNEOS smallpox and monkeypox vaccine, live 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464833 | modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464834 | modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection [Jynneos] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464834 | modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection [Jynneos] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2464837 | loteprednol etabonate 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2464838 | loteprednol etabonate 0.25 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2464838 | loteprednol etabonate 0.25 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464838 | loteprednol etabonate 0.25 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2464839 | Eysuvis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 246484 | acetaminophen 450 MG / orphenadrine 35 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246484 | acetaminophen 450 MG / orphenadrine 35 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246484 | acetaminophen 450 MG / orphenadrine 35 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464840 | loteprednol etabonate 2.5 MG/ML [Eysuvis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2464841 | loteprednol etabonate Ophthalmic Suspension [Eysuvis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2464842 | Eysuvis Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2464843 | EYsuVIS 0.25 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2464843 | EYsuVIS 0.25 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464843 | EYsuVIS 0.25 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2464843 | EYsuVIS 0.25 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 246485 | pyridoxine HCl 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246485 | pyridoxine HCl 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2464931 | magnesium potassium aluminosilicate fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2464936 | alpha-aminobutyric acid, L- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2464937 | Alpha aminobutyrate | Designated preferred name (PT) | NO | |
| RxCUI: 2464937 | Alpha aminobutyrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464937 | Alpha aminobutyrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2464937 | Alpha aminobutyrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2464937 | Alpha aminobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2464938 | cannabigerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246497 | sodium fluoride 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465 | Chondro-4-sulfatase | Designated preferred name (PT) | NO | |
| RxCUI: 2465 | Chondro-4-sulfatase | Full form of descriptor (FN) | NO | |
| RxCUI: 246501 | chloramphenicol 0.005 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246502 | ampicillin 250 MG / carbocysteine 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246503 | ampicillin 50 MG/ML / carbocysteine 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465039 | carbon dioxide 5 % / oxygen 20 % Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2465039 | carbon dioxide 5 % / oxygen 20 % Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246504 | netilmicin (as netilmicin sulfate) 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246504 | netilmicin (as netilmicin sulfate) 10 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 246504 | netilmicin (as netilmicin sulfate) 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246504 | netilmicin (as netilmicin sulfate) 10 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2465040 | benzalkonium chloride 0.15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2465040 | benzalkonium chloride 0.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2465040 | benzalkonium chloride 0.15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465041 | benzalkonium chloride 16.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2465042 | benzalkonium chloride 1.65 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2465042 | benzalkonium chloride 1.65 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2465042 | benzalkonium chloride 1.65 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246505 | netilmicin 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246506 | Ethambutol 300 MG / INH 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246506 | Ethambutol 300 MG / INH 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246507 | iodoquinol 42 MG/ML / metronidazole 40.2 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246507 | iodoquinol 42 MG/ML / metronidazole 40.2 MG/ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246508 | iodoquinol 325 MG / metronidazole 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246508 | iodoquinol 325 MG / metronidazole 250 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246513 | DES 120 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246513 | DES 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246514 | DES 60 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246514 | DES 60 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246515 | paramethasone 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246516 | paramethasone 20 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246517 | betamethasone dipropionate 5 MG/ML / betamethasone sodium phosphate 2 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246519 | chlormadinone acetate 2 MG / mestranol 0.08 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246521 | ethinyl estradiol 0.05 MG / levonorgestrel 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246521 | ethinyl estradiol 0.05 MG / levonorgestrel 0.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246521 | ethinyl estradiol 0.05 MG / levonorgestrel 0.25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246521 | ethinyl estradiol 0.05 MG / levonorgestrel 0.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246521 | ethinyl estradiol 0.05 MG / levonorgestrel 0.25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246522 | chlorproPAMIDE 125 MG / metFORMIN 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246522 | chlorproPAMIDE 125 MG / metFORMIN 400 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246523 | chlorpropamide 200 MG / phenformin 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246523 | chlorpropamide 200 MG / phenformin 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2465230 | 4-methyl-1-pentanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465231 | Cucumis melo root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465232 | N-acetylcaprolactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465233 | sodium bis(1,3-dimethylbutyl) sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2465234 | bis(1,3-dimethylbutyl) sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465235 | Astrocaryum vulgare kernel oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246524 | glyburide 5 MG / phenformin 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246524 | glyburide 5 MG / phenformin 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2465242 | casirivimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2465242 | casirivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2465242 | casirivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2465242 | casirivimab | Designated preferred name (PT) | YES | |
| RxCUI: 2465242 | casirivimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2465243 | casirivimab 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2465244 | casirivimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2465244 | casirivimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2465244 | casirivimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2465245 | casirivimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2465246 | casirivimab 1332 MG in 11.1 ML Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2465246 | casirivimab 1332 MG in 11.1 ML Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465246 | casirivimab 1332 MG in 11.1 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465247 | casirivimab 120 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465248 | casirivimab 300 MG in 2.5 ML Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2465248 | casirivimab 300 MG in 2.5 ML Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465248 | casirivimab 300 MG in 2.5 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465249 | imdevimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2465249 | imdevimab | Designated preferred name (PT) | YES | |
| RxCUI: 2465249 | imdevimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2465249 | imdevimab | Designated preferred name (PT) | YES | |
| RxCUI: 2465249 | imdevimab | Full form of descriptor (FN) | YES | |
| RxCUI: 246525 | chlorthalidone 10 MG / oxprenolol 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465250 | imdevimab 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2465251 | imdevimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2465251 | imdevimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2465251 | imdevimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2465252 | imdevimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2465253 | imdevimab 1332 MG in 11.1 MG Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2465253 | imdevimab 1332 MG in 11.1 MG Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465253 | imdevimab 1332 MG in 11.1 MG Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465254 | imdevimab 120 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465255 | imdevimab 300 MG in 2.5 ML Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2465255 | imdevimab 300 MG in 2.5 ML Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465255 | imdevimab 300 MG in 2.5 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246526 | chlorthalidone 20 MG / oxprenolol 160 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246527 | piretanide 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246528 | amiloride 4 MG / furosemide 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246528 | amiloride 4 MG / furosemide 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246529 | midodrine 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246530 | midodrine 2.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246531 | bencyclane 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246533 | sennosides, USP 185 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465331 | Tyblume Chewable 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2465331 | Tyblume Chewable 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465331 | Tyblume Chewable 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246535 | picosulfate sodium 7.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246536 | sodium lauryl sulfoacetate 9 MG/ML Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246538 | kaolin 197 MG/ML / pectin 44 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246540 | aluminum hydroxide 130 MG / milk of magnesia 165 MG Chewable Tab | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246540 | aluminum hydroxide 130 MG / milk of magnesia 165 MG Chewable Tab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246541 | aluminum hydroxide 185 MG / milk of magnesia 200 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246541 | aluminum hydroxide 185 MG / milk of magnesia 200 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465552 | magnesium sulfate / potassium chloride / sodium sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2465553 | magnesium sulfate / potassium chloride / sodium sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2465554 | magnesium sulfate 0.225 GM / potassium chloride 0.188 GM / sodium sulfate 1.479 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465554 | magnesium sulfate 0.225 GM / potassium chloride 0.188 GM / sodium sulfate 1.479 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465554 | magnesium sulfate 0.225 GM / potassium chloride 0.188 GM / sodium sulfate 1.479 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465554 | magnesium sulfate 0.225 GM / potassium chloride 0.188 GM / sodium sulfate 1.479 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465554 | magnesium sulfate 0.225 GM / potassium chloride 0.188 GM / sodium sulfate 1.479 GM Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2465555 | magnesium sulfate 225 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2465556 | SUTAB 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465556 | SUTAB 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465556 | SUTAB 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2465556 | SUTAB 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2465556 | SUTAB 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2465557 | magnesium sulfate / potassium chloride / sodium sulfate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2465558 | Sutab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2465559 | potassium chloride 188 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2465560 | sodium sulfate 1479 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2465561 | magnesium sulfate / potassium chloride / sodium sulfate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2465562 | magnesium sulfate 225 MG / potassium chloride 188 MG / sodium sulfate 1479 MG [Sutab] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2465563 | magnesium sulfate / potassium chloride / sodium sulfate Oral Tablet [Sutab] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2465564 | Sutab Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2465565 | Sutab Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 246557 | pipenzolate 4 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465570 | potato peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246558 | pipenzolate 4 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246559 | diphenidol 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246560 | meclizine 25 MG / vitamin B6 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246562 | meclizine 8.33 MG/ML / vitamin B6 16.7 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246565 | pancreatin 300 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246569 | pancreatin 170 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24657 | Exo-1,3-beta-glucosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24657 | Exo-1,3-beta-glucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 24657 | Exo-1,3-beta-glucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 246573 | chenodeoxycholic acid 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465730 | lidocaine hydrochloride 1.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2465730 | lidocaine hydrochloride 1.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2465730 | lidocaine hydrochloride 1.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2465731 | polyglyceryl-6 polyricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465732 | poloxamer 105 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2465733 | methyl abietate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465735 | edetic acid dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 246576 | pantothenic acid 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246577 | metoclopramide 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246578 | metoclopramide 0.66 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24658 | Exo-1,3-alpha-glucanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24658 | Exo-1,3-alpha-glucanase | Designated preferred name (PT) | NO | |
| RxCUI: 24658 | Exo-1,3-alpha-glucanase | Full form of descriptor (FN) | NO | |
| RxCUI: 2465830 | 3-iodo-2-propynol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465831 | ext. D&C yellow no. 7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465831 | ext. D&C yellow no. 7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2465834 | oleic acid ozonide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2465836 | Pterocarpus marsupium bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 246587 | ethyl loflazepate 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246588 | moclobemide 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246588 | moclobemide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246589 | penfluridol 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24659 | Beta-xylosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24659 | Beta-xylosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24659 | Beta-xylosidase | Designated preferred name (PT) | NO | |
| RxCUI: 24659 | Beta-xylosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 24659 | Beta-xylosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246590 | sulpiride 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246590 | sulpiride 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246591 | brotizolam 0.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246593 | phentermine 71 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246594 | phentermine 142 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246595 | aminohydroxybutyric acid 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246597 | aminohydroxybutyric acid 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246599 | vincamine 20 MG / vitamin C 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246599 | vincamine 20 MG / vitamin C 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246599 | vincamine 20 MG / vitamin C 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246599 | vincamine 20 MG / vitamin C 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24660 | Glucodextranase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24660 | Glucodextranase | Designated preferred name (PT) | NO | |
| RxCUI: 24660 | Glucodextranase | Full form of descriptor (FN) | NO | |
| RxCUI: 24660 | Glucodextranase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246603 | dipyrone 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246604 | dipyrone 5000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246607 | dipyrone 500 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246608 | dipyrone 300 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246609 | dipyrone 1000 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24661 | Exo-1,4-beta-glucosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24661 | Exo-1,4-beta-glucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 24661 | Exo-1,4-beta-glucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 246610 | dipyrone 400 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246611 | dipyrone 250 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246612 | dipyrone 400 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246613 | dipyrone 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246616 | chlormezanone 100 MG / dipyrone 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246617 | dipyrone 250 MG / scopolamine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246618 | dipyrone 500 MG/ML / scopolamine 4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246619 | dipyrone 333 MG/ML / scopolamine 6.67 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246620 | indomethacin 50 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246621 | nimesulide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246623 | clemizolpenicillin 400000 UNT Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246624 | clemizolpenicillin 1000000 UNT Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246625 | clemizolpenicillin 300000 UNT / penicillin G 100000 UNT Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246626 | clemizolpenicillin 800000 UNT / penicillin G 200000 UNT Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246628 | miocamycin 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246629 | miocamycin 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24663 | Exo cellobiohydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 24663 | Exo cellobiohydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 24663 | Exo cellobiohydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246630 | miocamycin 40 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246631 | nifurzide 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246632 | nifurzide 8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246633 | polynoxylin 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246634 | nifurzide 8 MG/ML / pectin 20 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246640 | ethinyl estradiol 30 MCG / gestodene 75 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246640 | ethinyl estradiol 30 MCG / gestodene 75 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246640 | ethinyl estradiol 30 MCG / gestodene 75 MCG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 246640 | ethinyl estradiol 30 MCG / gestodene 75 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246640 | ethinyl estradiol 30 MCG / gestodene 75 MCG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 246643 | cilazapril 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246644 | buthiazide 2.5 MG / metipranolol 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246645 | etilefrine 25 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246646 | etilefrine 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246647 | etilefrine 7.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24665 | Lambda exonuclease | Designated preferred name (PT) | NO | |
| RxCUI: 24665 | Lambda exonuclease | Full form of descriptor (FN) | NO | |
| RxCUI: 24665 | Lambda exonuclease | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246653 | fominoben 160 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246654 | fominoben 16 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246655 | ambroxol 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246656 | ambroxol 7.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246657 | carbocysteine 375 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246657 | carbocysteine 375 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246657 | carbocysteine 375 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 246657 | carbocysteine 375 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246657 | carbocysteine 375 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 246658 | carbocysteine 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24666 | Exodeoxyribonuclease I | Designated preferred name (PT) | NO | |
| RxCUI: 24666 | Exodeoxyribonuclease I | Full form of descriptor (FN) | NO | |
| RxCUI: 246661 | Carbocisteine 50 mg/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246661 | Carbocisteine 50 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 246661 | Carbocisteine 50 mg/mL oral solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246661 | Carbocisteine 50 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 24667 | Exodeoxyribonuclease III | Designated preferred name (PT) | NO | |
| RxCUI: 24667 | Exodeoxyribonuclease III | Full form of descriptor (FN) | NO | |
| RxCUI: 2466730 | alloxan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2466731 | Fucose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2466731 | Fucose | Designated preferred name (PT) | NO | |
| RxCUI: 2466731 | Fucose | Full form of descriptor (FN) | NO | |
| RxCUI: 24668 | E. coli exonuclease V | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24668 | E. coli exonuclease V | Designated preferred name (PT) | NO | |
| RxCUI: 24668 | E. coli exonuclease V | Full form of descriptor (FN) | NO | |
| RxCUI: 246687 | ambroxol 30 MG / clenbuterol 0.02 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246688 | ambroxol 3 MG/ML / clenbuterol 0.002 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246689 | ambroxol 7.5 MG/ML / clenbuterol 0.005 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24669 | Exodeoxyribonuclease VII | Designated preferred name (PT) | NO | |
| RxCUI: 24669 | Exodeoxyribonuclease VII | Full form of descriptor (FN) | NO | |
| RxCUI: 246690 | bromhexine 0.8 MG/ML / metaproterenol 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246693 | piperidolate 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246694 | amidoline 3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246695 | amidoline 3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246696 | amidoline 3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246697 | pirenzepine 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246698 | pirenzepine 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2466981 | polyglycolic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2466982 | polyglycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2466983 | Lactococcus lactis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 246699 | proglumide 300 MG / sulpiride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2466991 | diethylaminoethyl PEG-5 cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246700 | pipenzolate 4 MG/ML / simethicone 20 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246703 | veralipride 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246704 | dipyrone 500 MG / papaverine 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246705 | dipyrone 250 MG / pramiverine 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246706 | dipyrone 500 MG/ML / pramiverine 4 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246707 | APAP 300 MG / Ketoprofen 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246707 | APAP 300 MG / Ketoprofen 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246708 | APAP 17 MG/ML / Ketoprofen 6 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246708 | APAP 17 MG/ML / Ketoprofen 6 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246710 | benzbromarone 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467130 | phenyl acetaldehyde dimethyl acetal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467131 | polyquaternium-10 (20000 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467132 | Pyrola asarifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467134 | isocyclocitral | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467137 | Mitracarpus hirtus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 246714 | FESO4 270 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246714 | FESO4 270 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467140 | lumasiran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2467140 | lumasiran | Designated preferred name (PT) | YES | |
| RxCUI: 2467140 | lumasiran | Full form of descriptor (FN) | YES | |
| RxCUI: 2467140 | lumasiran | Designated preferred name (PT) | YES | |
| RxCUI: 2467140 | lumasiran | Full form of descriptor (FN) | YES | |
| RxCUI: 2467141 | isoeugenyl benzyl ether, (Z)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467143 | acetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467144 | 4-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467144 | 4-cresol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467148 | amisulpride 10 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467148 | amisulpride 10 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467148 | amisulpride 10 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467148 | amisulpride 10 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467149 | Barhemsys 10 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467149 | Barhemsys 10 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467149 | Barhemsys 10 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467149 | Barhemsys 10 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467149 | Barhemsys 10 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246715 | FESO4 400 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246715 | FESO4 400 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467150 | lumasiran 189 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2467151 | lumasiran Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2467151 | lumasiran Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2467151 | lumasiran Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2467152 | lumasiran Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2467153 | lumasiran 94.5 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467153 | lumasiran 94.5 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467153 | lumasiran 94.5 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467153 | lumasiran 94.5 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467154 | Oxlumo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2467155 | lumasiran 189 MG/ML [Oxlumo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2467156 | lumasiran Injection [Oxlumo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2467157 | Oxlumo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467158 | OXLUMO 94.5 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467158 | OXLUMO 94.5 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467158 | OXLUMO 94.5 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467158 | OXLUMO 94.5 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467158 | OXLUMO 94.5 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467159 | lumasiran 189 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467160 | lumasiran 189 MG/ML Injection [Oxlumo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2467160 | lumasiran 189 MG/ML Injection [Oxlumo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467161 | lumasiran sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2467161 | lumasiran sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2467161 | lumasiran sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2467163 | Nizoral Psoriasis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2467164 | salicylic acid 30 MG/ML [Nizoral Psoriasis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2467165 | salicylic acid Medicated Shampoo [Nizoral Psoriasis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2467166 | Nizoral Psoriasis Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467167 | Nizoral Psoriasis 3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467167 | Nizoral Psoriasis 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467167 | Nizoral Psoriasis 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467167 | Nizoral Psoriasis 3 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 246718 | teferrol 31.2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467180 | petrolatum 60 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467180 | petrolatum 60 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467180 | petrolatum 60 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246721 | vitamin K 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246723 | vitamin K 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246724 | idoxuridine 0.002 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246726 | chloramphenicol 5 MG/ML / dexamethasone 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246726 | chloramphenicol 5 MG/ML / dexamethasone 1 MG/ML Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246727 | chloramphenicol 1 MG/ML / prednisolone 5 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246727 | chloramphenicol 1 MG/ML / prednisolone 5 MG/ML Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2467276 | 3A,4,5,6,7,7A-hexahydro-1H-4,7-methanoinden-6-yl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467277 | polyglyceryl-3 caprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2467278 | butyl hexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467279 | heliotropine butane-2,3-diol acetal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 246728 | fluorometholone 1 MG/ML / tetrahydrozoline 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246730 | dexamethasone 1 MG/ML / phenylephrine 1.5 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246730 | dexamethasone 1 MG/ML / phenylephrine 1.5 MG/ML Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246731 | polymyxin B 16.2 UNT/MG / triamcinolone 0.001 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246734 | tetrahydrozoline 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246736 | antazoline 5 MG/ML / naphazoline 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246737 | naphazoline 0.16 MG/ML / pheniramine 3 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246739 | pirenoxine 0.05 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24674 | Exopolygalacturonase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 24674 | Exopolygalacturonase | Designated preferred name (PT) | NO | |
| RxCUI: 24674 | Exopolygalacturonase | Full form of descriptor (FN) | NO | |
| RxCUI: 24674 | Exopolygalacturonase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246741 | benzocaine 5 MG / dequalinium 0.25 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246744 | lidocaine 50 MG/ML / tribenoside 20 MG/ML Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246745 | lidocaine 400 MG / tribenoside 40 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246746 | clostebol 5 MG/ML / neomycin 3.5 MG/ML Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246747 | clostebol 5 MG/ML / neomycin 3.5 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246749 | flumethasone 0.0002 MG/MG / neomycin 0.005 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24675 | Exopolygalacturonate lyase | Designated preferred name (PT) | NO | |
| RxCUI: 24675 | Exopolygalacturonate lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 246751 | bifonazole 0.01 MG/MG / urea 0.4 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246752 | clotrimazole 10 MG/ML / dexamethasone 0.4 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246752 | clotrimazole 10 MG/ML / dexamethasone 0.4 MG/ML Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 246753 | clioquinol 30 MG/ML / flumethasone 0.2 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467530 | baloxavir marboxil Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2467534 | Xofluza Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467536 | baloxavir marboxil Granules for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2467537 | baloxavir marboxil 40 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467537 | baloxavir marboxil 40 MG Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467538 | baloxavir marboxil Granules for Oral Suspension [Xofluza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2467539 | Xofluza 40 MG Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467539 | Xofluza 40 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467539 | Xofluza 40 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246754 | clioquinol 0.03 MG/MG / flumethasone 0.0002 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467540 | berotralstat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2467540 | berotralstat | Designated preferred name (PT) | YES | |
| RxCUI: 2467540 | berotralstat | Full form of descriptor (FN) | YES | |
| RxCUI: 2467540 | berotralstat | Designated preferred name (PT) | YES | |
| RxCUI: 2467540 | berotralstat | Full form of descriptor (FN) | YES | |
| RxCUI: 2467541 | Berotralstat dihydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467541 | Berotralstat dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2467541 | Berotralstat dihydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 2467541 | Berotralstat dihydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2467542 | capromorelin 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2467543 | capromorelin 20 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467543 | capromorelin 20 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467544 | Elura | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2467545 | capromorelin 20 MG/ML [Elura] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2467546 | capromorelin Oral Solution [Elura] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2467547 | Elura Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2467548 | Elura Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2467549 | Elura 20 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2467549 | Elura 20 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467549 | Elura 20 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246755 | clioquinol 0.03 MG/MG / fluocinonide 0.0005 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467550 | fluorbenside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467551 | disintegrin and metalloproteinase domain-containing protein 11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467552 | Eryngium maritimum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467553 | lonafarnib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2467553 | lonafarnib | Designated preferred name (PT) | YES | |
| RxCUI: 2467553 | lonafarnib | Full form of descriptor (FN) | YES | |
| RxCUI: 2467553 | lonafarnib | Designated preferred name (PT) | YES | |
| RxCUI: 2467553 | lonafarnib | Full form of descriptor (FN) | YES | |
| RxCUI: 2467554 | peppermint oil terpeneless | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2467561 | berotralstat 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2467562 | berotralstat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2467562 | berotralstat Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2467562 | berotralstat Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2467563 | berotralstat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2467564 | berotralstat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2467565 | berotralstat 150 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2467565 | berotralstat 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467565 | berotralstat 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467565 | berotralstat 150 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2467566 | Orladeyo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2467567 | berotralstat 150 MG [Orladeyo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2467568 | berotralstat Oral Capsule [Orladeyo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2467569 | Orladeyo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467570 | Orladeyo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467571 | orladeyo 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467571 | orladeyo 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467571 | orladeyo 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467572 | berotralstat 110 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2467573 | berotralstat 110 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2467573 | berotralstat 110 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467573 | berotralstat 110 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467573 | berotralstat 110 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2467574 | berotralstat 110 MG [Orladeyo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2467575 | orladeyo 110 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467575 | orladeyo 110 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467575 | orladeyo 110 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467578 | lonafarnib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2467579 | lonafarnib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2467579 | lonafarnib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2467579 | lonafarnib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 246758 | clioquinol 30 MG/ML / triamcinolone 0.1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467580 | lonafarnib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2467581 | lonafarnib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2467582 | lonafarnib 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467582 | lonafarnib 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2467582 | lonafarnib 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467582 | lonafarnib 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2467583 | Zokinvy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2467584 | lonafarnib 50 MG [Zokinvy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2467585 | lonafarnib Oral Capsule [Zokinvy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2467586 | Zokinvy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467587 | Zokinvy Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2467588 | Zokinvy 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467588 | Zokinvy 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467588 | Zokinvy 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2467589 | lonafarnib 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 246759 | clioquinol 30 MG/ML / triamcinolone 1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467590 | lonafarnib 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467590 | lonafarnib 75 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2467590 | lonafarnib 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2467590 | lonafarnib 75 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2467591 | lonafarnib 75 MG [Zokinvy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2467592 | Zokinvy 75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2467592 | Zokinvy 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2467592 | Zokinvy 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 24676 | Exopolyphosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 24676 | Exopolyphosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 246765 | amcinonide 0.25 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246766 | chloramphenicol 0.01 MG/MG / collagenase 0.00064 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246767 | methoxsalen 7.5 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246768 | methoxsalen 0.004 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246769 | copper sulfate 1.2 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 24677 | Exoribonuclease H | Designated preferred name (PT) | NO | |
| RxCUI: 24677 | Exoribonuclease H | Full form of descriptor (FN) | NO | |
| RxCUI: 246770 | clostebol 5 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246773 | asiaticoside 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467730 | Achillea millefolium root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467736 | Jock-Eze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2467737 | clotrimazole 10 MG/ML [Jock-Eze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2467738 | clotrimazole Topical Cream [Jock-Eze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2467739 | Jock-Eze Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 246774 | asiaticoside 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467740 | JOCK-EZE 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2467740 | JOCK-EZE 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467740 | JOCK-EZE 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467740 | JOCK-EZE 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467741 | camphor 3.5 % / menthol 3.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467741 | camphor 3.5 % / menthol 3.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467741 | camphor 3.5 % / menthol 3.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467743 | cetylpyridinium chloride 0.05 % / sodium fluoride 0.05 % (fluoride ion 0.02 % ) Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467743 | cetylpyridinium chloride 0.05 % / sodium fluoride 0.05 % (fluoride ion 0.02 % ) Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467743 | cetylpyridinium chloride 0.05 % / sodium fluoride 0.05 % (fluoride ion 0.02 % ) Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467748 | Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2467748 | Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 246776 | asiaticoside 0.01 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246777 | tribenoside 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246778 | Dornase Alfa 2500 UNT / SK 10000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246778 | Dornase Alfa 2500 UNT / SK 10000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246781 | polidocanol 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246782 | polidocanol 30 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467839 | 2-amino-1,3-propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467840 | betulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467841 | menhaden oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2467842 | PEG-6 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2467844 | menthol 9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2467845 | menthol 0.9 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467845 | menthol 0.9 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467845 | menthol 0.9 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467846 | chlorhexidine gluconate 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467846 | chlorhexidine gluconate 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2467846 | chlorhexidine gluconate 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246793 | ranitidine 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467997 | ethanol 0.743 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2467998 | ethanol 74.3 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2467998 | ethanol 74.3 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2467998 | ethanol 74.3 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468 | Chondroitin ABC eliminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468 | Chondroitin ABC eliminase | Designated preferred name (PT) | NO | |
| RxCUI: 2468 | Chondroitin ABC eliminase | Full form of descriptor (FN) | NO | |
| RxCUI: 24680 | Exosurf | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2468050 | ethyl methoxycinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468051 | polyethyloxazoline (5000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468052 | propylene glycol 1-oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468053 | Imoxi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2468054 | imidacloprid 100 MG/ML / moxidectin 25 MG/ML [Imoxi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2468055 | imidacloprid / moxidectin Topical Solution [Imoxi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2468056 | Imoxi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2468057 | IMOXI 10 % / 2.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2468057 | IMOXI 10 % / 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468057 | IMOXI 10 % / 2.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2468058 | Nymyo 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2468058 | Nymyo 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2468058 | Nymyo 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 246810 | allyl sulfide 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246811 | phenformin hydrochloride 50 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246812 | phenformin hydrochloride 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246820 | vit-C 100 MG / ZnSO4 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246820 | vit-C 100 MG / ZnSO4 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246820 | vit-C 100 MG / ZnSO4 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246821 | coal tar 20 MG/ML / salicylic acid 20 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468230 | tozinameran | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2468230 | tozinameran | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2468231 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2468232 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2468233 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2468234 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2468235 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 30 MCG/0.3 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2468235 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 30 MCG/0.3 ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2468235 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 30 MCG/0.3 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2468236 | acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2468237 | DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2468237 | DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2468237 | DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2468238 | acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Vaxelis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2468239 | Vaxelis 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2468239 | Vaxelis 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2468239 | Vaxelis 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2468240 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468241 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 246828 | pancreatin 500 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246829 | activated charcoal 500 MG / simethicone 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246830 | flosequinan 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246830 | flosequinan 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468309 | tasimelteon 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2468310 | tasimelteon Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2468311 | tasimelteon Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2468312 | tasimelteon 4 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2468312 | tasimelteon 4 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2468313 | tasimelteon 4 MG/ML [Hetlioz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2468314 | tasimelteon Oral Suspension [Hetlioz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2468315 | Hetlioz Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2468316 | Hetlioz LQ 4 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2468316 | Hetlioz LQ 4 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2468316 | Hetlioz LQ 4 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2468316 | Hetlioz LQ 4 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2468333 | salicylic acid 0.015 MG/MG [Super Spot Remover] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2468334 | Super Spot Remover 1.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2468334 | Super Spot Remover 1.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468334 | Super Spot Remover 1.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2468334 | Super Spot Remover 1.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246839 | bran Oral Wafer | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2468409 | ethanol 0.643 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2468410 | ethanol 64.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468410 | ethanol 64.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2468410 | ethanol 64.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468411 | ethanol 78 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468411 | ethanol 78 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2468411 | ethanol 78 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246842 | bismuth subnitrate 130 MG / cerium oxalate 130 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468430 | glucose glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468431 | Morus nigra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468433 | hydroxypropyl methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2468434 | hydroquinine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2468435 | hydroquinine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468436 | Aluminum magnesium hydroxide carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2468436 | Aluminum magnesium hydroxide carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246851 | Cyanocobalamin 100 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246851 | Cyanocobalamin 100 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246858 | calcium polycarbophil 1250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 246858 | calcium polycarbophil 1250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 246869 | Dibasic K+ phosphate 150 MMOLE Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246869 | Dibasic K+ phosphate 150 MMOLE Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 246869 | Dibasic K+ phosphate 150 MMOLE Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468738 | methyl salicylate 25 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2468738 | methyl salicylate 25 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468738 | methyl salicylate 25 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2468739 | Eucutasol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2468740 | coal tar 20 MG/ML [Eucutasol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2468741 | coal tar Topical Cream [Eucutasol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2468742 | Eucutasol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2468743 | EuCutaSol 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2468743 | EuCutaSol 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2468743 | EuCutaSol 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2468743 | EuCutaSol 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2469134 | camphor 0.015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2469135 | camphor 1.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2469135 | camphor 1.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2469135 | camphor 1.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2469136 | camphor 1.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2469136 | camphor 1.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2469136 | camphor 1.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2469137 | camphor 1.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2469137 | camphor 1.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2469137 | camphor 1.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2469236 | Pterocarpus marsupium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2469238 | Salvia lavandulifolia leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2469242 | acetyl arginine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469243 | 1-chloro-2-methyl-1-propene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469244 | loureirin B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2469245 | maltooligosyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469246 | HC red no. 3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469247 | setmelanotide | Full form of descriptor (FN) | YES | |
| RxCUI: 2469247 | setmelanotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469247 | setmelanotide | Designated preferred name (PT) | YES | |
| RxCUI: 2469247 | setmelanotide | Full form of descriptor (FN) | YES | |
| RxCUI: 2469247 | setmelanotide | Designated preferred name (PT) | YES | |
| RxCUI: 2469248 | setmelanotide acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2469248 | setmelanotide acetate | Designated preferred name (PT) | NO | |
| RxCUI: 2469248 | setmelanotide acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 2469249 | indol-3-yl sodium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469250 | didecyldimonium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2469250 | didecyldimonium bromide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2469251 | Ancylostoma caninum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2469330 | carbazochrome sodium sulfonate hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2469332 | disodium ascorbyl sitostanol phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2469333 | pegfilgrastim-apgf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2469334 | pegfilgrastim-apgf 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2469335 | pegfilgrastim-apgf 6 MG in 0.6 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2469335 | pegfilgrastim-apgf 6 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2469335 | pegfilgrastim-apgf 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469336 | Nyvepria | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2469337 | pegfilgrastim-apgf 10 MG/ML [Nyvepria] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2469338 | pegfilgrastim Prefilled Syringe [Nyvepria] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2469339 | Nyvepria Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2469340 | Nyvepria 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469340 | Nyvepria 6 MG in 0.6 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2469340 | Nyvepria 6 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2469340 | Nyvepria 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469341 | pegfilgrastim-apgf 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2469342 | pegfilgrastim-apgf 10 MG/ML Prefilled Syringe [Nyvepria] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2469342 | pegfilgrastim-apgf 10 MG/ML Prefilled Syringe [Nyvepria] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2469343 | setmelanotide 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2469344 | setmelanotide Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2469344 | setmelanotide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2469344 | setmelanotide Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2469345 | setmelanotide Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2469346 | setmelanotide 10 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 2469346 | setmelanotide 10 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| RxCUI: 2469346 | setmelanotide 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469346 | setmelanotide 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2469346 | setmelanotide 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2469347 | Imcivree | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2469348 | setmelanotide 10 MG/ML [Imcivree] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2469349 | setmelanotide Injectable Solution [Imcivree] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2469350 | Imcivree Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2469351 | IMCIVREE 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469351 | IMCIVREE 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2469351 | IMCIVREE 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469351 | IMCIVREE 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2469352 | beta-eleostearic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 24698 | fludarabine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 24698 | fludarabine | Designated preferred name (PT) | YES | |
| RxCUI: 24698 | fludarabine | Full form of descriptor (FN) | YES | |
| RxCUI: 24698 | fludarabine | Designated preferred name (PT) | YES | |
| RxCUI: 24698 | fludarabine | Full form of descriptor (FN) | YES | |
| RxCUI: 2469930 | polyethylenimine hydrochloride (20000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2469933 | Wilzin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2469934 | zinc acetate 25 MG [Wilzin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2469935 | zinc acetate Oral Capsule [Wilzin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2469936 | Wilzin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2469937 | Wilzin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2469938 | Wilzin 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2469938 | Wilzin 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2469938 | Wilzin 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |